Jeudan A/S
F:0AZ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jeudan A/S
F:0AZ
|
DK |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
R
|
Relx PLC
DUS:RDEB
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0AZ's stock price target?
Not Available
0AZ does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Jeudan A/S?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 12 years is -3%.
What is the Gross Profit forecast for Jeudan A/S?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 12 years is -4%.
What is the Operating Income forecast for Jeudan A/S?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 12 years is 0%.
What is the Pre-Tax Income forecast for Jeudan A/S?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 33%. The projected CAGR for the next 12 years is -3%.
What is the Net Income forecast for Jeudan A/S?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Net Income has been 33%. The projected CAGR for the next 12 years is -6%.